Zampieri, C., Kouhmareh, K., Sartipdolagh, P., Azmoon, P., Klemke, R. L., Gonias, S. L. (2025). The urokinase receptor/uPAR is a major effector of p53 gain-of-function mutations in gemcitabine-treated pancreatic ductal adenocarcinoma. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110561